Migraine drug race turns its final corner, FDA decisions in sight
Nat Biotechnol
.
2018 Mar 6;36(3):207-208.
doi: 10.1038/nbt0318-207.
Author
Elie Dolgin
PMID:
29509726
DOI:
10.1038/nbt0318-207
No abstract available